Durlax Top Surface Other Announcement

Durlax Top Surface Annual General Meeting

Durlax Top Surface Limited held its Annual General Meeting on September 24, 2026. The meeting covered standard agenda items including adoption of financial statements and appointments.

Durlax Top Surface Credit Rating

Acuité Ratings & Research upgraded and assigned credit ratings for Durlax Top Surface Limited’s banking facilities. The company maintains a Stable outlook.

Durlax Top Surface Annual General Meeting

Durlax Top Surface Limited has scheduled its Annual General Meeting for September 24, 2026. Key agenda items include adopting financial statements and director re-appointment.

Durlax Top Surface Q1 FY27 Results: Net Profit ₹2.8 Cr, Up 115.4% YoY

Durlax Top Surface Ltd reported revenue from operations of ₹56 Cr (+89.2% YoY) and net profit of ₹2.8 Cr (+115.4% YoY) for Q1 FY27.

Key figure

Net profit ₹2.8 Cr · +115.4% YoY

Durlax Top Surface Board Meeting Date

Durlax Top Surface Limited has scheduled a board meeting on August 14, 2026. The board will consider unaudited standalone financial results for the June 2026 quarter.

Durlax Top Surface Capital Structure Change

Durlax Top Surface allotted 1.03 crore warrants at Rs. 47.50 each. The company received Rs. 12.25 Crore as 25% upfront payment from 12 investors.

Value

₹12.25 Cr

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.